Alzheimer’s drug slows down human thinking, hailed as ‘historic moment’
An experimental medicine has delayed the rate of decline in memory and cognition among persons with early Alzheimer’s disease. It’s the first time medicine has been shown to influence the disease’s course. Eisai is recruiting people with a high risk of Alzheimer’s but no symptoms to take part in more trials. In what is being … Read more